Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Thomas Biehl
Erratum To: Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival
Annals of Surgical Oncology
Oncology
Surgery
Related publications
Sustained CA19-9 Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer Predicts Progression and Survival
Oncologist
Cancer Research
Medicine
Oncology
Operative Outcomes Following Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy (Sbrt) for Borderline Resectable and Locally Advanced Pancreatic Cancer
HPB
Hepatology
Gastroenterology
A Pilot Study- Neoadjuvant Chemotherapy With Gemcitabine and S1 in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Journal of Carcinogenesis & Mutagenesis
Preoperative Nomogram to Predict Survival for Patients With Resectable and Borderline Resectable Pancreatic Cancer
HPB
Hepatology
Gastroenterology
Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials
Journal of Clinical Medicine
Outcomes With FOLFIRINOX for Borderline Resectable and Locally Unresectable Pancreatic Cancer
Journal of Surgical Oncology
Medicine
Surgery
Oncology
Folfirinox Neoadjuvant Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer - A Retrospective Study
International Journal of Contemporary Medical Research [IJCMR]
Management of Borderline Resectable Pancreatic Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Neoadjuvant Imatinib for Borderline Resectable GIST
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
